by Truveta Staff | Mar 18, 2024 | Research, Technology
Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout February 2024 (-20.0%) compared to January 2024. While COVID- and influenza-associated hospitalizations decreased (-26.5% and -22.7%), all other respiratory viruses...
by Truveta Staff | Mar 13, 2024 | News, Technology
Truveta has won the 2024 South by Southwest Innovation Award in Artificial Intelligence for its AI-enabled health research and the Truveta Language Model (TLM). TLM is a large-language, multi-modal AI model for transforming electronic health record (EHR) data into...
by Truveta Staff | Mar 12, 2024 | Technology
Stories from women whose endometriosis pain has been dismissed are devastatingly common. A typical woman in the United States will wait 10 years after her symptoms first appear to receive an endometriosis diagnosis. This delay is rooted in a pervasive lack of...
by Truveta Staff | Mar 11, 2024 | Technology
Each year, approximately 900,000 patients in the US are affected by a pulmonary embolism (PE), a blood clot causing a blockage in one or more pulmonary arteries in the lungs. PE is a leading cause of in-hospital death in the US, and acute PE – a sudden blockage...
by Michael Simonov, MD | Feb 29, 2024 | News, Technology
Healthcare data traditionally has been too siloed, inaccessible, and messy to be useful for research. And one of the biggest challenges has been that critical information about a patient’s health is locked away in the unstructured text in clinician notes. Thanks to...
by Truveta Staff | Feb 23, 2024 | Research, Technology
Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout January 2024 (-35.3%) compared to December 2023. The largest decreases were seen in parainfluenza virus- (-49.0%), RSV- (-48.0%), and influenza-associated (-41.6%)...